Abstract
To analyze the mechanism by which nitric oxide (NO) exerts its antisteroidogenic action, human luteal cells were cultured during 24 and 48 h with l-arginine (l-Arg, 1 mmol/L); 1,2(2-trifluoromethylphenyl)imidazole (TRIM) (50 μmol/L and 1 mmol/L) and cyclic guanosine monophosphate (cGMP) analog (8-Br-cGMP, 1 mmol/L). Estradiol, nitrite, and P450 AROM activity were determined in culture media. Total cGMP concentration was evaluated in the cells and culture media by radioimmunoassay, and NADPH diaphorase was used as a histochemical marker for NO synthase (NOS) activity. During the corpus luteum (CL) life-span, NO affected estradiol secretion in an age-dependent manner, with an inhibition in mid-CL (37%; p<0.05) in agreement with our previous results, and no significant modification in early and late CL. Basal nitrite concentration in 24 and 48 h of midluteal cell cultures (42 and 93 pmol/106 cells, respectively) was increased by l-Arg (53% and 88%) and inhibited by the two TRIM concentrations; also, an intense diaphorase reactivity was observed in endothelial cells and luteal parenchyma. Total cGMP was not detected in cell cultures and 8-Br-cGMP did not modify estradiol secretion, whereas aromatase activity was strongly inhibited by l-Arg (70%, p<.05). These results suggest that both NOS isoforms are active in midluteal cells, and the mechanism of action for NO on in vitro estradiol secretion may be an inhibition of P450 AROM activity.
Similar content being viewed by others
References
Castro, A., Castro, O., Troncoso, J. L., Kohen, P., Simón, C., Vega, M., and Devoto, L. (1998). Human Reprod. 13, 1584–1589.
Jo, T., Nobuyuki, T., Takauchi, Y., Saji, F., Nishizawa, Y., Tanaka, S., and Kosaka, H. (1995). J Steroid Biochem Mol Biol. 55, 291–296.
Johnson, M. C., Devoto, L., Retamales, I., Kohen, P., Troncoso, J. L., and Aguilera, G. (1996). Fertil Steril. 65:489–494.
Vega, M., Carrasco, I., Castillo, T., Troncoso, J. L., Videla, L. A., and Devoto, L. (1995). J Endocrinol. 147, 177–182.
Ahsan, S., Lacey, M., and Whitehead, S. A. (1997). Eur J Endocrinol. 137, 293–300.
Olson, L. M., Jones-Burton, C. M., and Jablonka-Shariff, A. (1996). Endocrinology 137, 3531–3539.
Van Voorhis, B. J., Dunn, M. S., Snyder, G. D., and Weiner, C. P. (1994). Endocrinology 135, 1799–1806.
Zackrisson, U., Mikuni, M., Wallin, A., Delbro, D., Hedin, L., and Brannstrom, M. (1996). Hum Reprod. 11, 2667–2673.
Vega, M., Johnson, M. C., Diaz, H. A., Urrutia, L. R., Troncoso, J. L., and Devoto, L. (1998). Endocrine 8, 185–191.
Welch, C., Watson, M. E., Poth, M., Hong, T., and Francis, G. L. (1995). Metabolism 44, 234–238.
Lowenstein, C. J. and Snyder, S. H. (1992). Cell 70, 705–707.
Moncada, S. and Higgs, E. A. (1995). FASEB J 9, 1319–1330.
Nathan, C. and Xie, Q. (1994). Cell 78 915–918.
Marletta, M. A. (1994). Cell 78, 927–930.
Snyder, G. D., Holmes R. W., Bates, J. N., and Van Voorhis B. J. (1996). J. Steroid Biochem Mol. Biol. 58, 63–69.
Handy, R. L. C., Harb, H. L., Wallace, P., Gaffen, Z., Whitehead, K. J., and Moore, P. K. (1996). Br J Pharmacol. 119, 423–431.
Tracy, W. R., Nakane, M., Pollock, J. S., and Forsterman, U. (1993). Biochem Biophys Res Commun. 195, 1035–1040.
Lei, Z. M., Chegini, N. Rao, and Ch. V. (1991). Biol Reprod. 44, 1148–1156.
Brannstrom, M., Pascoe, V., Norman, R. J., and McClure, N. (1994). Fertil Steril. 61, 488–495.
Brunswig-Spickenheier, B., and Mukhopadhyay, A. K. (1997). Biol Reprod. 57, 700–706.
Elman, C., Corbett, J. A., Misko, T. P., McDaniel, M., and Beckerman, K. P. (1993). J Clin Invest. 92, 3053–3056.
LaPolt, P. S. and Hong, L-S. (1995). Endocrinology. 136, 5533–5539.
Doody, K. J., Lorence, M. C., Mason, J. I., and Simpson E. R. (1990). J Clin Endocrinol Metab. 70, 1041–1045.
Simpsom, E. R., Mahendroo M. S., Means, G. D., Kilgore M. W., Hinshelwood, M. M., Graham-Lorence, S., Amarneh, B., Ito, Y., Fisher, C. R., Michael, M. D., Mendelson, C. R., and Bulun, S. E. (1994). Endocr Rev. 15, 342–355.
Stamler, J. S. (1994). Cell 78, 931–936.
Vega, M., Devoto, L., Castro, O., and Kohen, P. (1994). J Clin Endocrinol. Metab. 79, 466–469.
Boric, M. P. and Croxatto, H. R. (1995). Hypertension 26, 1167–1172.
Samlowski, W. E., Yim, C. Y., and McGregor, J. R. (1998). Nitric Oxide. 2, 45–56.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Johnson, M.C., Diaz, H.A., Stocco, C. et al. Antisteroidogenic action of nitric oxide on human corpus luteum in vitro. Endocr 11, 31–36 (1999). https://doi.org/10.1385/ENDO:11:1:31
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1385/ENDO:11:1:31